LNCD(SH:600739) Ren Min Ri Bao·2025-09-07 22:16Core Points - The China-ASEAN Regional Pharmaceutical Trading (Procurement) Platform has successfully completed its first cross-border online transaction and settlement, marking a significant milestone for Chinese pharmaceutical companies aiming to expand into ASEAN and SCO countries [1] Group 1 - The platform was officially launched in January 2025 and is the first cross-border regional pharmaceutical procurement platform guided by the National Medical Security Administration [1] - The transaction involved Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. and a party from Singapore, demonstrating the platform's capability as a convenient and secure channel for international trade [1] - The establishment of this platform indicates its maturity in serving Chinese pharmaceutical enterprises in their overseas endeavors [1]